Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Chikungunya virus impairs draining lymph node function by inhibiting HEV-mediated lymphocyte recruitment
Mary K. McCarthy, … , Heather D. Hickman, Thomas E. Morrison
Mary K. McCarthy, … , Heather D. Hickman, Thomas E. Morrison
Published July 12, 2018
Citation Information: JCI Insight. 2018;3(13):e121100. https://doi.org/10.1172/jci.insight.121100.
View: Text | PDF
Research Article Immunology Infectious disease

Chikungunya virus impairs draining lymph node function by inhibiting HEV-mediated lymphocyte recruitment

  • Text
  • PDF
Abstract

Chikungunya virus (CHIKV) causes acute and chronic rheumatologic disease. Pathogenic CHIKV strains persist in joints of immunocompetent mice, while the attenuated CHIKV strain 181/25 is cleared by adaptive immunity. We analyzed the draining lymph node (dLN) to define events in lymphoid tissue that may contribute to CHIKV persistence or clearance. Acute 181/25 infection resulted in dLN enlargement and germinal center (GC) formation, while the dLN of mice infected with pathogenic CHIKV became highly disorganized and depleted of lymphocytes. Using CHIKV strains encoding ovalbumin-specific TCR epitopes, we found that lymphocyte depletion was not due to impaired lymphocyte proliferation. Instead, the accumulation of naive lymphocytes transferred from the vasculature to the dLN was reduced, which was associated with fewer high endothelial venule cells and decreased CCL21 production. Following NP-OVA immunization, NP-specific GC B cells in the dLN were decreased during pathogenic, but not attenuated, CHIKV infection. Our data suggest that pathogenic, persistent strains of CHIKV disable the development of adaptive immune responses within the dLN.

Authors

Mary K. McCarthy, Bennett J. Davenport, Glennys V. Reynoso, Erin D. Lucas, Nicholas A. May, Susan A. Elmore, Beth A. Tamburini, Heather D. Hickman, Thomas E. Morrison

×

Figure 2

Decreased lymphocyte numbers and altered lymphocyte subset localization in the dLN after pathogenic CHIKV infection.

Options: View larger image (or click on image) Download as PowerPoint
Decreased lymphocyte numbers and altered lymphocyte subset localization ...
(A) Total cells in dLN. Mock (gray), 181/25 (blue), AF15561 (red). Total numbers of (B) B220+ cells, (C) CD4+ T cells, and (D) CD8+ T cells in the dLN. Data are derived from 2–3 independent experiments per time point. Each data point represents the mean ± SEM of 9–11 (1 dpi), 6–10 (3 dpi), 6–8 (5 dpi), 4–5 (7 dpi), or 7–8 (10 dpi) mice per group. *P < 0.05, **P < 0.01, ***P < 0.001; two-way ANOVA with Bonferroni’s post hoc test. Statistical significance is only displayed for comparison of 181/25 and AF15561 groups. (E) Confocal micrographs showing ERTR-7+ stromal cells (red), B220+ B cells (blue), and CD8+ T cells (green) in the dLN at the indicated time points. White dashed line in mock LN outlines B cell follicles. Images are representative of 3–6 dLNs per group per time point. Scale bars: 200 μm.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts